Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lansoprazole for prevention of aspirin-associated gastric and duodenal ulcers
jRCT2080220484Phase 3
- Sponsor
- Takeda
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of lansoprazole in gastric ulcer, duodenal ulcer and Peptic ulcer disease (PUD), sponsored by Takeda. Primary endpoint: Incidence of gastric and duodenal ulcers.
02
Drugs
lansoprazole
03
Conditions
gastric ulcerduodenal ulcerPeptic ulcer disease (PUD)
Beyond the preview
Go deeper on jRCT2080220484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220484.